title: Immunotherapy meets targeted therapy: will this team end the war against cancer?
abstract: Cancer treatment as we know it today has dramatically changed over the last couple of decades. It has moved from non-specific treatment to personalized approaches. As oncologist, we now have further understanding of the processes leading to carcinogenesis; this has led to develop new therapeutic options. We have cytotoxic treatments, targeted therapy and in recent years, immunotherapy; the time to "mix and match" has begun.
authors.affiliation: 1 Rosell Oncology Institute, Quirón-Dexeus University Hospital, Barcelona, Spain ; 2 Pangaea Biotech, Barcelona, Spain ; 3 Institut Quimic de Sarriá, Barcelona, Spain ; 4 Institut Catalá d'Oncologia, Badalona, Spain.
authors.forename: Daniela
authors.initials: D
authors.lastname: Morales-Espinosa
authors.affiliation: 1 Rosell Oncology Institute, Quirón-Dexeus University Hospital, Barcelona, Spain ; 2 Pangaea Biotech, Barcelona, Spain ; 3 Institut Quimic de Sarriá, Barcelona, Spain ; 4 Institut Catalá d'Oncologia, Badalona, Spain.
authors.forename: Silvia
authors.initials: S
authors.lastname: García-Román
authors.affiliation: 1 Rosell Oncology Institute, Quirón-Dexeus University Hospital, Barcelona, Spain ; 2 Pangaea Biotech, Barcelona, Spain ; 3 Institut Quimic de Sarriá, Barcelona, Spain ; 4 Institut Catalá d'Oncologia, Badalona, Spain.
authors.forename: Cristina
authors.initials: C
authors.lastname: Teixidó
authors.affiliation: 1 Rosell Oncology Institute, Quirón-Dexeus University Hospital, Barcelona, Spain ; 2 Pangaea Biotech, Barcelona, Spain ; 3 Institut Quimic de Sarriá, Barcelona, Spain ; 4 Institut Catalá d'Oncologia, Badalona, Spain.
authors.forename: Niki
authors.initials: N
authors.lastname: Karachaliou
authors.affiliation: 1 Rosell Oncology Institute, Quirón-Dexeus University Hospital, Barcelona, Spain ; 2 Pangaea Biotech, Barcelona, Spain ; 3 Institut Quimic de Sarriá, Barcelona, Spain ; 4 Institut Catalá d'Oncologia, Badalona, Spain.
authors.forename: Rafael
authors.initials: R
authors.lastname: Rosell
keywords: Immunotherapy; cancer; combination therapy; personalized treatment; targeted therapy